Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant.
Tan, Clara S H
Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant. [electronic resource] - European journal of human genetics : EJHG 04 2020 - 518-520 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1476-5438
10.1038/s41431-019-0561-8 doi
Adult
Diabetes Mellitus, Type 2--drug therapy
Dipeptidyl-Peptidase IV Inhibitors--therapeutic use
Hepatocyte Nuclear Factor 1-alpha--genetics
Humans
Hypoglycemic Agents--therapeutic use
Incretins--therapeutic use
Male
Mutation
Pedigree
Pharmacogenomic Variants
Sulfonylurea Compounds--therapeutic use
Treatment Outcome
Response to multiple glucose-lowering agents in a sib-pair with a novel HNF1α (MODY3) variant. [electronic resource] - European journal of human genetics : EJHG 04 2020 - 518-520 p. digital
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
1476-5438
10.1038/s41431-019-0561-8 doi
Adult
Diabetes Mellitus, Type 2--drug therapy
Dipeptidyl-Peptidase IV Inhibitors--therapeutic use
Hepatocyte Nuclear Factor 1-alpha--genetics
Humans
Hypoglycemic Agents--therapeutic use
Incretins--therapeutic use
Male
Mutation
Pedigree
Pharmacogenomic Variants
Sulfonylurea Compounds--therapeutic use
Treatment Outcome